Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab

Thyroid dysfunction (TD) induced by immune checkpoint inhibitors is not sufficiently understood. The purpose of this retrospective observational study was to identify risk factors and the clinical course of TD induced by nivolumab. Patients with advanced solid tumors who were treated with nivolumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimbara, Shiro, Fujiwara, Yutaka, Iwama, Shintaro, Ohashi, Ken, Kuchiba, Aya, Arima, Hiroshi, Yamazaki, Naoya, Kitano, Shigehisa, Yamamoto, Noboru, Ohe, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215874/
https://www.ncbi.nlm.nih.gov/pubmed/30230649
http://dx.doi.org/10.1111/cas.13800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215874/
https://www.ncbi.nlm.nih.gov/pubmed/30230649
http://dx.doi.org/10.1111/cas.13800

Ejemplares similares